SUDD inhibitors, also known as suicide inhibitors or mechanism-based inhibitors, are a class of chemical compounds designed to interfere with the activity of specific enzymes within biological systems. These inhibitors are distinct in their mechanism of action, which involves forming a covalent bond with the target enzyme, rendering it permanently inactive. The term suicide inhibitor aptly describes this irreversible binding process, as the inhibitor essentially sacrifices itself in the process of deactivating the enzyme. The mechanism of action of SUDD inhibitors begins with the compound being recognized by the target enzyme, often due to its structural similarity to the enzyme's natural substrate. Once bound to the enzyme's active site, the inhibitor undergoes a chemical transformation, usually involving a reaction that generates a highly reactive intermediate or radical species. This intermediate then reacts with essential amino acid residues within the enzyme's active site, forming a stable covalent bond.
As a result of this covalent modification, the enzyme's catalytic activity is permanently disrupted. This process is akin to a chemical suicide for the inhibitor, as it becomes irreversibly bound to the enzyme and is no longer available for other reactions.SUDD inhibitors find extensive use in biochemical and pharmacological research to elucidate enzyme function and explore potential drug targets. They are invaluable tools for understanding enzyme kinetics, substrate specificity, and the role of specific enzymes in various biological pathways. Overall, SUDD inhibitors play a crucial role in advancing our understanding of enzymatic processes and have broad applications in both basic research and drug development.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Irreversibly inhibits cyclooxygenase, reducing prostaglandin production and inflammation. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Covalently binds to the H+/K+ ATPase pump in gastric parietal cells, reducing acid secretion in the stomach. | ||||||
Warfarin | 81-81-2 | sc-205888 sc-205888A | 1 g 10 g | $73.00 $246.00 | 7 | |
Interferes with vitamin K-dependent clotting factors, inhibiting blood coagulation. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Inhibits xanthine oxidase, reducing the conversion of xanthine to uric acid and preventing gout attacks. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Blocks the tyrosine kinase activity of BCR-ABL, inhibiting the growth of cancer cells in chronic myeloid leukemia. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Binds to glutamate-gated chloride channels in parasites, leading to paralysis and death of the parasites. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Inhibits HIV protease, preventing the cleavage of viral polyproteins and reducing the production of mature virions. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Reversibly inhibits acetylcholinesterase, increasing acetylcholine levels. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Competes with estrogen for binding to the estrogen receptor, inhibiting the growth of estrogen-dependent breast cancer cells. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
Blocks angiotensin-converting enzyme (ACE), reducing the formation of angiotensin II and lowering blood pressure. | ||||||